Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell S Cairo

Showing results (91-100 of 298) with videos related to

Pageof 30
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
A pilot study of chemoimmunotherapy (cyclophosphamide, prednisone, and rituximab) in patients with post-transplant lymphoproliferative disorder following solid organ transplantationManuela Orjuela, Thomas G Gross, Ying-Kuen Cheung, et al.
Experimental Hematology|December 13, 2005
Increased induction of allogeneic-specific cord blood CD4+CD25+ regulatory T (Treg) cells: a comparative study of naïve and antigenic-specific cord blood Treg cellsChih-Chao Chang, Prakash Satwani, Nora Oberfield, et al.
British Journal of Haematology|September 17, 2013
Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children's Oncology Group ReportPaul J Galardy, Jessica Hochberg, Sherrie L Perkins, et al.
Pediatric Blood & Cancer|April 19, 2018
Mycophenolate mofetil administered every 8 hours in combination with tacrolimus is efficacious in the prophylaxis of acute graft versus host disease in childhood, adolescent, and young adult allogeneic stem cell transplantation recipientsOlga Militano, Mehmet F Ozkaynak, Brinda Mehta, et al.
Pediatric Blood & Cancer|September 15, 2006
A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipientsEvan B Shereck, Erin Cooney, Carmella van de Ven, et al.
Molecular Therapy. Oncology|October 20, 2025
Advances in augmenting infiltration of active natural killer cells into pediatric and adult solid tumorsShiori Eguchi, Wen Luo, Hongwen Zhu, et al.
Pediatric Radiology|May 3, 2003
Periostitis secondary to interleukin-11 (Oprelvekin, Neumega). Treatment for thrombocytopenia in pediatric patientsEdward Milman, Walter E Berdon, James H Garvin, et al.
American Journal of Clinical Pathology|March 17, 2004
Comparative immunohistochemical analysis of pediatric Burkitt lymphoma and diffuse large B-cell lymphomaMichael Frost, James Newell, Mark A Lones, et al.
Clinical Lymphoma|January 8, 2005
Assessing immunoglobulin heavy chain rearrangements in pediatric CD20-positive and CD20-negative classic Hodgkin's diseaseBruce Shiramizu, Sherrie L Perkins, Sharon Bergeron, et al.
Pediatric Blood & Cancer|August 3, 2007
Reduced intensity and non-myeloablative allogeneic stem cell transplantation in children and adolescents with malignant and non-malignant diseasesPrakash Satwani, Erin Morris, M Brigid Bradley, et al.
Pageof 30

Showing results (91-100 of 298) with videos related to

Sort By:
Pageof 30
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
A pilot study of chemoimmunotherapy (cyclophosphamide, prednisone, and rituximab) in patients with post-transplant lymphoproliferative disorder following solid organ transplantationManuela Orjuela, Thomas G Gross, Ying-Kuen Cheung, et al.
Experimental Hematology|December 13, 2005
Increased induction of allogeneic-specific cord blood CD4+CD25+ regulatory T (Treg) cells: a comparative study of naïve and antigenic-specific cord blood Treg cellsChih-Chao Chang, Prakash Satwani, Nora Oberfield, et al.
British Journal of Haematology|September 17, 2013
Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children's Oncology Group ReportPaul J Galardy, Jessica Hochberg, Sherrie L Perkins, et al.
Pediatric Blood & Cancer|April 19, 2018
Mycophenolate mofetil administered every 8 hours in combination with tacrolimus is efficacious in the prophylaxis of acute graft versus host disease in childhood, adolescent, and young adult allogeneic stem cell transplantation recipientsOlga Militano, Mehmet F Ozkaynak, Brinda Mehta, et al.
Pediatric Blood & Cancer|September 15, 2006
A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipientsEvan B Shereck, Erin Cooney, Carmella van de Ven, et al.
Molecular Therapy. Oncology|October 20, 2025
Advances in augmenting infiltration of active natural killer cells into pediatric and adult solid tumorsShiori Eguchi, Wen Luo, Hongwen Zhu, et al.
Pediatric Radiology|May 3, 2003
Periostitis secondary to interleukin-11 (Oprelvekin, Neumega). Treatment for thrombocytopenia in pediatric patientsEdward Milman, Walter E Berdon, James H Garvin, et al.
American Journal of Clinical Pathology|March 17, 2004
Comparative immunohistochemical analysis of pediatric Burkitt lymphoma and diffuse large B-cell lymphomaMichael Frost, James Newell, Mark A Lones, et al.
Clinical Lymphoma|January 8, 2005
Assessing immunoglobulin heavy chain rearrangements in pediatric CD20-positive and CD20-negative classic Hodgkin's diseaseBruce Shiramizu, Sherrie L Perkins, Sharon Bergeron, et al.
Pediatric Blood & Cancer|August 3, 2007
Reduced intensity and non-myeloablative allogeneic stem cell transplantation in children and adolescents with malignant and non-malignant diseasesPrakash Satwani, Erin Morris, M Brigid Bradley, et al.
Pageof 30